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Background: The aim of this study was to evaluate the diagnostic
utility of endobronchial ultrasound (EBUS)-guided transbronchial
biopsy (TBB) using a novel 3.4-mm thin bronchoscope and a
1.4-mm ultrasonic probe for peripheral pulmonary lesions.
Methods: A total of 86 patients with suspected peripheral lesions
were included in this prospective study. EBUS-TBBs were per-
formed using a prototype 3.4-mm thin bronchoscope and a 1.4-mm
radial ultrasonic probe under fluoroscopic guidance.
Results: Twelve patients with endobronchial lesions within the
segmental bronchi and three patients who did not return to follow-up
were excluded from this analysis. Thus, a total of 71 patients with
peripheral pulmonary lesions (mean size, 31.2  12.7 mm) were
included in the final analysis. The mean bronchus level reached with
the thin bronchoscope was 4.6 generations. Diagnostic histologic
specimens were obtained in 49 of 71 patients (69%:80% for malig-
nant lesions and 52% for benign lesions). A definitive diagnosis of
malignancy for lesions 20 mm and lesions 20 mm was made in
82% (31 of 38) and 67% (four of six), respectively. There were no
significant complications.
Conclusion: The EBUS-TBB using a 3.4-mm thin bronchoscope
and a 1.4-mm radial probe is feasible, accurate, and safe for the
diagnosis of peripheral pulmonary lesions.
Key Words: Bronchoscopy, Endobronchial ultrasound, Lung can-
cer, Peripheral pulmonary lesions, Thin bronchoscope.
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In an effort to enhance the diagnostic accuracy of bronchoscopyfor peripheral pulmonary lesions, several ancillary technolo-
gies have been proposed, such as thin bronchoscopy,1–4 endo-
bronchial ultrasound (EBUS),5,6 navigational bronchoscopy,6–8
and computed tomography (CT) fluoroscopy.9 Each of them has
remarkable features, and the combination of these modalities is
likely to be promising for better bronchoscopy.6
Innovative technology has permitted the development
of a new, thinner, and better-visibility flexible bronchoscope
with a working channel, which allows the use of a thin EBUS
probe. The aim of this study was to assess the ability of
EBUS-guided transbronchial biopsy (TBB) using a 3.4-mm
hybrid-bronchofibervideoscope with a 1.7-mm working chan-
nel and a 1.4-mm ultrasonic probe to diagnose peripheral
pulmonary lesions.
PATIENTS AND METHODS
Patients
This prospective study was approved by the institu-
tional review board of our hospital and registered with the
University Hospital Medical Information Network-Clinical
Trials Registry, UMIN000000509. Informed consent was
obtained from all patients. From March 2006 to March 2007,
86 patients were enrolled with localized peripheral pulmo-
nary lesions, such as a solitary pulmonary nodule, a pulmo-
nary mass, or a localized infiltrate, referred for diagnostic
bronchoscopy. Patients with diffuse pulmonary lesions were
excluded from this study.
Equipment
A prototype thin bronchoscope (XBF-3B260Y1; Olym-
pus, Tokyo, Japan, 3B260) and a thin ultrasonic probe
(XUM-S20-17R; Olympus) were used (Figure 1). The 3B260
is a hybrid bronchofibervideoscope, which incorporates a
charge-coupled device in the control section. It has a 3.4-mm
distal end diameter, a 1.7-mm working channel diameter,
210° up and 130° down angulation, a 90° field of view, and
a 2–50-mm depth of field. The EBUS procedures were
performed with an endoscopic ultrasound center (EU-M 30;
Olympus) and the XUM-S20-17R, which is a 20-MHz me-
chanical radial type, reusable, and direct-contact ultrasonic
probe with an external diameter of 1.4 mm.
Procedures
Bronchoscopic procedures were performed using con-
scious sedation with bolus intravenous midazolam and local
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anesthesia with lidocaine by staff pulmonologists or super-
vised pulmonary residents of our institution. A 5.0-mm inner
diameter endotracheal tube was placed transnasally under
thin bronchoscopic control, which facilitated repeated inser-
tion and removal of the bronchoscope, and then the tracheo-
bronchial tree was examined in standard fashion using the
3B260. After examining the endobronchial region, the 3B260
was advanced toward the bronchus most likely leading to the
lesion under direct vision. Then, a thin ultrasonic probe was
passed through the working channel and advanced to the
lesion under bronchoscopic control with fluoroscopic visual-
ization. If the lesion surrounding the probe was clearly
visualized by EBUS, the bronchus in which the probe passed
through could be the correct route leading to the target lesion.
After determining the leading bronchus to the lesion, the
3B260 was further advanced as far as possible using the
probe as a guide and wedged into the peripheral bronchus.
After that, the probe was removed, and TBB was performed
using a 1.5-mm forceps (FB-32D, Olympus) under fluoro-
scopic guidance. Ten biopsy specimens were taken from each
lesion, and each specimen was then transferred into separate
containers filled with formalin for histologic examination.
After TBB, washing in the corresponding bronchus for cyto-
logic and cultural examination was performed with 10 to 20
mL of saline solution. Other procedures such as brushing,
curettage, or needle aspiration biopsy for the target lesion
were not performed in the same setting. A chest radiograph
was obtained routinely to identify pneumothorax after the
procedures.
Diagnosis
All malignant diagnoses were confirmed pathologi-
cally. The benign diagnoses were established by surgical
procedure, microbiological analysis including tuberculosis or
nontuberculous mycobacteriosis, or clinical follow-up. An
inconclusive histologic diagnosis of nonspecific fibrosis or
inflammation was considered to be nondiagnostic.
Statistical Analysis
The lesions located within the segmental bronchi that
were defined as central lesions10 were excluded in this analysis.
Means and percentages were presented as appropriate. The
accuracies were calculated using the standard definitions. Re-
sults were analyzed using Pearson 2 test. Statistical analyses
were performed using a statistical software program (JMP; SAS
Institute, Cary, NC). Results were considered statistically sig-
nificant when the p value was less than or equal to 0.05.
RESULTS
An endobronchial lesion within the segmental bronchus
that was defined as a central lesion was identified with the
3B260 in 12 patients. Another three patients did not return to
follow-up. Thus, a total of 71 patients (45 men and 26
women; mean age, 67.2 years; range, 45–85 years) with
peripheral pulmonary lesions (mean  SD size, 31.2  12.7
mm; range, 8–70 mm) were included in the final analysis.
Table 1 details the results of EBUS-TBB with the 3B260.
A histologic diagnosis was made in 49 of 71 patients (69%).
The diagnostic yields for malignant lesions and benign lesions
were 80% (35 of 44) and 52% (14 of 27), respectively (p 
0.02). The sensitivity, specificity, negative predictive value,
positive predictive value, and accuracy for diagnosing malig-
nancy were 80%, 100%, 75%, 100%, and 87%, respectively.
Table 2 shows the diagnostic yield of this procedure
related to the lesion size, which was determined by measuring
the greatest diameter on CT. Diagnostic yield was higher for
the lesions 20 mm in size (44 of 57, 77%) than 20 mm in
size (5 of 14, 36%) (p  0.003).
FIGURE 1. A comparison of bronchoscopes. A, Thin bron-
choscope (XBF-3B260Y1, 3.4-mm distal end diameter,
Olympus, Tokyo, Japan) and thin ultrasonic probe (XUM-
S20-17R; Olympus). B, Standard bronchoscope (BF-1T260,
5.9-mm distal end diameter; Olympus).
TABLE 1. Final Diagnoses and Results of EBUS-TBB with
Thin Bronchoscope in 71 Patients
Histologic Findings Patients (Diagnosis)
Malignant
Adenocarcinoma 14
Squamous cell carcinoma 14
Small cell carcinoma 1
Non-small cell carcinoma 4
Metastatic adenocarcinoma 1 (Colon)
Metastatic squamous cell
carcinoma
1 (Maxillary sinus)
Benign
Organizing pneumonia 6
Epithelioid cell granuloma
with or without necrosis
5 (Three nontuberculous mycobacteriosis,
one tuberculosis, and one unspecified)
Inflammatory pseudotumora 1
Pulmonary abscess 1
Typical carcinoida 1
Nondiagnostic
Suspected lung cancer 4 (Four lung cancer)
Nonrepresentative samples 18 (Five lung cancer, one nontuberculous
mycobacteriosis,a five improved, and
seven unchanged with 12–25-mo
follow-up)
Data are presented as n.
a Surgically confirmed.
EBUS-TBB, endobronchial ultrasound-guided transbronchial biopsy.
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Table 3 shows the diagnostic yield and inserted bron-
chial generation of thin bronchoscopy according to the bron-
chopulmonary segments. The 3B260 could be inserted into
4.6-generation bronchi on average (range, 2nd–7th genera-
tion). Endobronchial abnormalities such as exophitic endo-
bronchial mass, submucosal spread, or peribronchial tumor
causing extrinsic compression that presented beyond the
segmental bronchi were visualized with the 3B260 in 14
patients (20%). The diagnostic yield was not affected by the
lobar location of the lesions (p  0.91).
The lesion was localized with EBUS in 65 patients (92%).
On the EBUS image, the ultrasonic probe could be inserted into
the target lesion in 51 patients (72%), the probe could not be
inserted into the target lesion but reached the margin of the
lesion in 14 patients (20%), and the lesion could not be visual-
ized in six patients (8%). The diagnostic yield related to the
location of the probe in relation to the target lesion was 82% (42
of 51), 42% (6 of 14), and 17% (one of six) (p  0.001).
A representative case with a successfully diagnosed
peripheral pulmonary lesion (adenocarcinoma; measuring 18
mm in diameter) is shown in Figures 2 and 3.
There were no significant procedure-related complica-
tions, such as major bleeding or pneumothorax.
DISCUSSION
To our knowledge, this is the first report on the utility
of EBUS-TBB using a thin bronchoscope for making a
pathologic diagnosis of localized peripheral pulmonary le-
sions. Using this method, a diagnostic histologic specimen
was obtained in 69% of patients with peripheral pulmonary
lesions. The diagnostic yield for malignant lesions was as
high as 80% (35 of 44), even excluding 9% (4 of 44) of
suspicious results for malignancy.
With the progress of technologies, thinner broncho-
scopes with a working channel and dedicated biopsy instru-
ments have been developed, and several investigators1–3,11,12
have reported its utility for evaluating peripheral pulmonary
lesions. Nevertheless, the clinical application of thin bron-
choscopy for investigating peripheral pulmonary lesions has
been quite limited because of the limitations of the small
TABLE 2. Diagnostic Yield of EBUS-TBB with Thin
Bronchoscope According to Lesion Size
Lesion Size
Lesions Diagnosed/Lesions Examined
Malignant Benign Total
20 mm 4/6 (67) 1/8 (13) 5/14 (36)
20 mm 31/38 (82) 13/19 (68) 44/57 (77)
Total 35/44 (80) 14/27 (52) 49/71 (69)
Data are presented as n (%). Diagnostic yield for lesions20 mm vs.20 mm; p
0.003 using the 2 test. Diagnostic yield for malignant lesions vs. benign lesions; p 
0.02 using the 2 test.
EBUS-TBB, endobronchial ultrasound-guided transbronchial biopsy.
TABLE 3. Diagnostic Yield and Inserted Bronchial
Generation of Thin Bronchoscopy in Relation to
Bronchopulmonary Segments
Segments
Bronchial Generation
Inserted
Lesions Diagnosed/Lesions
Examined
RUL 4.8  1.3 16/24 (67)
RML 4.6  1.1 3/5 (60)
RLL 4.5  1.2 14/18 (78)
LUL 4.6  1.5 9/14 (64)
Lingula 6.0 1/1 (100)
LLL 4.1  0.8 6/9 (67)
Data are presented as mean  SD or n (%). Diagnostic yield in the location of the
lesions; p  0.91 using the 2 test.
RUL, right upper lobe; RML, right middle lobe; RLL, right lower lobe; LUL, left
upper lobe; LLL, left lower lobe.
FIGURE 2. Lung cancer (adenocarcinoma) measuring 18
mm in the right upper lobe. A, Fluoroscopic images of trans-
bronchial biopsy using XBF-3B260Y1. B, Computed tomog-
raphy (CT) image. C, Ultrasonic image.
FIGURE 3. Thin bronchoscopic views: (A) 2nd, (B) 3rd, (C)
4th, (D) 5th, (E) 6th, and (F) 7th generation bronchi visual-
ized by the thin bronchoscope are shown. F, Thin broncho-
scope could be inserted as far as the 6th generation bron-
chus and ultrasonic probe (arrow) was inserted into the 7th
generation bronchus under direct vision.
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1.2-mm working channel including its limited ability to
sample specimens or poor suction capability.1,2,8 The devel-
opment of an even thinner bronchoscope with greater visual
range, improved visibility, and a larger working channel
would assure more effective clinical application.
In a former study,4 we demonstrated the utility of an
exprototype thin fiberoptic bronchoscope with a 1.7-mm
working channel (XBF-3B40Y1, 3.5-mm distal end diameter;
Olympus) for the examination of peripheral pulmonary le-
sions. The thin bronchoscope could enter a further two distal
generations of bronchi from the bronchi reached by a stan-
dard bronchoscope, and it revealed 14% of lesions that could
not be visualized with the standard bronchoscope. A diag-
nostic histologic specimen with TBB using the thin broncho-
scope under fluoroscopic guidance was obtained in 65% of
patients (72% for malignant lesions and 50% for benign
lesions). The new 1.7-mm channel can accommodate a wider
variety of bronchoscopic instruments including a larger bi-
opsy forceps in comparison with the conventional 1.2-mm
channel of thin bronchoscopes. Additionally, it has enabled
thin bronchoscopic EBUS-TBB using a thin ultrasonic probe.
Comparison with our former study was not the purpose of this
study. Although the enhancement of the diagnostic yield
seems to be limited, we prefer to use the EBUS in thin
bronchoscopy, because it provides some valuable information
at the time of the procedure. In this study, as reported by the
other investigator,5 the locational relationship between the
examining bronchus and the target lesion on EBUS image
was a good predictor of the adequacy of the procedure. It also
provides the bronchologist with immediate feedback to mod-
ify the technique or biopsy site accordingly. Furthermore, it
might be possible to determine whether or not the lesion is
malignant from the ultrasonic features.13 The overall diag-
nostic yield is likely to depend on the prevalence of disease.
In this investigation, the diagnostic yield of thin broncho-
scopic EBUS-TBB in benign lesions, especially small benign
lesions, was significantly lower than the yield in malignant
lesions. The difficulty to establish a specific benign diagnosis
is a common problem for biopsy procedures including bron-
choscopy and CT-guided transthoracic needle aspiration. A
recent review article14 reported nondiagnostic biopsy results
of CT-guided transthoracic needle biopsy in 44% of patients
with benign nodules. Nonspecific benign results should be
interpreted carefully considering the pretest probability of
malignancy.
Several investigators6–8 have reported the utility of
navigational bronchoscopy in the diagnosis of peripheral
pulmonary lesions. The combination of a thin bronchoscope
and navigational bronchoscopy seems reasonable. The bron-
chial map provided by a navigational device may be useless
if the bronchoscope or a biopsy instrument cannot follow the
indicated route. The good bronchial selectivity and smooth
maneuverability of a thin bronchoscope in the peripheral
airway provide a surer means to follow the indicated bron-
chial route correctly. The combination of the present method
and navigational technology can thus make the best of mutual
abilities, and it may lead to enhanced diagnostic yield.
The safety and good tolerability of thin bronchoscopy
with a 1.7-mm channel have been reported in our previous
study.4,15 This study further demonstrated the safety of the
procedures with a thin bronchoscope with a 1.7-mm channel.
In conclusion, EBUS-TBB using a 3.4-mm thin broncho-
scope and a 1.4-mm radial probe is feasible, accurate, and safe
for the diagnosis of peripheral pulmonary lesions, especially
malignant lesions. To elucidate in more detail the usefulness of
this procedure, prospective comparison with EBUS-TBB using
a conventional bronchoscope may be needed.
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